Cargando…
Preclinical pharmacology, efficacy, and safety of varenicline in smoking cessation and clinical utility in high risk patients
Smoking is still the most prominent cause of preventable premature death in the United States and an increasing cause of morbidity and mortality throughout the world. Although the current treatments such as nicotine replacement therapy (NRT) and bupropion are effective, long-term abstinence rates ar...
Autor principal: | Xi, Zheng-Xiong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028205/ https://www.ncbi.nlm.nih.gov/pubmed/21278851 |
Ejemplares similares
-
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
por: Ebbert, Jon O, et al.
Publicado: (2010) -
Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
por: Ahmed, Saeed, et al.
Publicado: (2018) -
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008) -
Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015) -
Smoking cessation: an economic analysis and review of varenicline
por: Faulkner, Michele A
Publicado: (2009)